In thyroid cancer, Cui et al. reported that 3-deazaneplanocin A (DZNep) may cause the accumulation of p53 protein by upregulating USP10 expression, thereby activating the p53 pathway and ultimately inhibiting the growth of TP53 wild-type thyroid cancer cells (83). The gene discussed is TP53; the disease is thyroid gland carcinoma.